Role of the complement components C5 and C3a in a mouse model of myocardial ischemia and reperfusion injury (original) (raw)
Complement component 3 is necessary to preserve myocardium and myocardial function in chronic myocardial infarction
Mitesh Solanki
STEM CELLS, 2014
View PDFchevron_right
Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury
Manfred Dahm
The Journal of pharmacology and experimental therapeutics, 1998
View PDFchevron_right
Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium
P. Laurila
The American journal of pathology, 1994
View PDFchevron_right
Complement activation in heart diseases
Malay Mandal
Cellular Signalling, 2000
View PDFchevron_right
Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury
Ahvie Herskowitz
Circulation, 1993
View PDFchevron_right
Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury
Marcela Pekna
PloS one, 2017
View PDFchevron_right
Anti-ischemia/reperfusion of C1 inhibitor in myocardial cell injury via regulation of local myocardial C3 activity
Dongxu Liu
Biochemical and Biophysical Research Communications, 2006
View PDFchevron_right
Targeted Complement Inhibitors Protect against Posttransplant Cardiac Ischemia and Reperfusion Injury and Reveal an Important Role for the Alternative Pathway of Complement Activation
Stephen Tomlinson, Sarah Stephenson, Carl Atkinson
2010
View PDFchevron_right
C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion
Robert Veerhuis, Paul A J Krijnen
European Journal of Clinical Investigation, 2004
View PDFchevron_right
Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730)
Edward Smith
European Journal of Pharmacology, 1993
View PDFchevron_right
C5aR-mediated myocardial ischemia/reperfusion injury
Dongxu Liu
Biochemical and Biophysical Research Communications, 2007
View PDFchevron_right
Recombinant Human Complement C5a Receptor Antagonist Reduces Infarct Size After Surgical Revascularization
James Jordan
The Journal of …, 2000
View PDFchevron_right
Complement Factor C5a Mediates Renal Ischemia-Reperfusion Injury Independent from Neutrophils
Jörg Köhl
The Journal of Immunology, 2003
View PDFchevron_right
Functional assessment of rat complement pathway activities and quantification of soluble C5b-9 in an experimental model of renal ischemia/reperfusion injury
Mohamed Daha
Journal of Immunological Methods
View PDFchevron_right
Posttransplant Ischemia-Reperfusion Injury In Transplanted Heart Is Prevented By A Minibody to the Fifth Component of Complement
P. Macor, Mariano Ferraresso, Paolo Durigutto
Transplantation, 2008
View PDFchevron_right
Complement-Dependent Inflammation and Injury in a Murine Model of Brain Dead Donor Hearts
Carl Atkinson
Circulation Research, 2009
View PDFchevron_right
Enhancing complement control on endothelial barrier reduces renal dysfunction following ischemia/reperfusion injury
John Barker
The Faseb Journal, 2010
View PDFchevron_right
Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion
Louis Matis
Circulation, 1998
View PDFchevron_right
Regulation of complement membrane attack complex formation in myocardial infarction
P. Laurila
The American journal of pathology, 1993
View PDFchevron_right
Complement C3c as a Biomarker in Heart Failure
Ulrich Hofmann
Mediators of Inflammation, 2013
View PDFchevron_right
The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization
Trent Woodruff
Proceedings of the National Academy of Sciences, 2013
View PDFchevron_right
An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction
Grace L Su
Journal of Experimental Medicine, 2006
View PDFchevron_right
Pharmacology and Biological Efficacy of a Recombinant, Humanized, Single-Chain Antibody C5 Complement Inhibitor in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass
gary kopf
2010
View PDFchevron_right
C-Reactive Protein Activates Complement in Infarcted Human Myocardium
Wim Lagrand
The American Journal of Pathology, 2003
View PDFchevron_right
A Novel Targeted Inhibitor of the Alternative Pathway of Complement and Its Therapeutic Application in Ischemia/Reperfusion Injury
Carl Atkinson
The Journal of Immunology, 2008
View PDFchevron_right
CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?
Wim Lagrand
International Immunopharmacology, 2001
View PDFchevron_right
Expression of the complement C3a and C5a receptors after permanent focal ischemia: An alternative interpretation
Ricardo Ames
Glia, 2002
View PDFchevron_right
Inhibiting the complement system does not reduce injury in renal ischemia reperfusion
Patrick Cunningham, Richard Quigg
Journal of the American Society of Nephrology : JASN, 2001
View PDFchevron_right
Complement C5a inhibition improves late hemodynamic and inflammatory changes in a rat model of nonocclusive mesenteric ischemia
József Kaszaki
Surgery, 2015
View PDFchevron_right
Role for the Alternative Complement Pathway in Ischemia/Reperfusion Injury
Michael Fung
The American Journal of Pathology, 2003
View PDFchevron_right
Serum complement activation in congestive heart failure
Tarik Ramahi
American Heart Journal, 2001
View PDFchevron_right
Neutrophils Ischemia-Reperfusion Injury Independent Complement Factor C 5 a Mediates Renal and
Wim Buurman
2003
View PDFchevron_right
Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction
Christopher Adlbrecht, Johannes Jakowitsch
Thrombosis and Haemostasis, 2009
View PDFchevron_right